Zhixian Wu
6PUBLICATIONS
16CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Oct 07, 2025
OCIAD2 as a novel prognostic and therapeutic biomarker for pancreatic cancer: A study based on transcriptomic signature and bioinformatics analysis.Zhongyuan Cui, Xia Lei, Yani Gou
|Jul 08, 2023
Trajectories of α-fetoprotein and unresectable hepatocellular carcinoma outcomes receiving atezolizumab plus bevacizumab: a secondary analysis of IMbrave150 study.Linbin Lu, Peichan Zheng, Yan Pan
|Mar 27, 2023
Fas/FasL and Complement Activation are Associated with Chronic Active Epstein-Barr Virus Hepatitis.Jing Lin, Miao-Fang Su, Jiao-Long Zheng
|Oct 06, 2021
The significance of Stanniocalcin 2 in malignancies and mechanisms.Shasha Li, Qian Huang, Dongliang Li
|Aug 30, 2021
High mRNA Expression of CENPL and Its Significance in Prognosis of Hepatocellular Carcinoma Patients.Zhongyuan Cui, Lijia Xiao, Fengsui Chen
|Apr 08, 2020
STC2 Is a Potential Prognostic Biomarker for Pancreatic Cancer and Promotes Migration and Invasion by Inducing Epithelial-Mesenchymal Transition.Chen Lin, Lina Sun, Shenglei Huang
Pageof 1
Frequent Collaborators
2 joint publications
Dongliang Li
2 joint publications
Zhongyuan Cui
1 joint publications
Jing Lin
1 joint publications
Lei Gu
1 joint publications
Chen Lin
1 joint publications
Lina Sun
1 joint publications
Shenglei Huang
1 joint publications
Xiangqun Weng
1 joint publications
Linbin Lu
1 joint publications
Peichan Zheng
